Cipla Palliative Care Centre completes 15 years of caring for advanced stage cancer patients

Cipla announces Q2 FY 1213 Unaudited Financial Results

WHO Prequalifies A New Artemisinin-Based Combination Treatment (ACT) for Malaria

Cipla launches Qvir, a once-daily novel 4 drug kit for HIV/AIDS

Cipla announces Q1 FY 1213 Unaudited Financial Results

DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination

Cipla announces the appointment of Mr. Frank Pieters as the Head of European Region and Global Respiratory Business

Cipla continues to care for cancer patients! ~Announces a breakthrough price reduction on selected cancer drugs~

Cipla and DNDi announce the forthcoming launch of Artesunate + Mefloquine Fixed-Dose combination for P.falciparum malaria

Cipla introduces new pain free screening technology for early detection of breast cancer in India - ‘No Touch Breast Scan’